Status:
COMPLETED
Participation Restrictions in Breast Cancer Survivors
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-59 years
Phase:
NA
Brief Summary
This project will develop and preliminarily evaluate an intervention to assist young-middle adult rural breast cancer survivors to overcome functional impairments related to their cancer treatment. Yo...
Eligibility Criteria
Inclusion
- Female breast cancer patient stages I-III.
- Age 18-59.
- Completion of definitive breast cancer treatment (i.e., subsequent to loco-regional surgical treatment and completion of adjuvant or neo-adjuvant chemotherapy with or without radiation) within the past 3-6 months.
- Screen positive for a moderate or worse level of participation restriction (Work and Social Adjustment Scale score \> 10) within 6 months following cancer treatment.
- English speaking.
- Have a land-based phone or reliable cell phone reception.
Exclusion
- Non-correctable hearing loss.
- Moderate-severe cognitive impairment indicated by a score \< 3 on a 6-item cognitive screener.
- Medical record documentation of severe mental illness (i.e., schizophrenia or bipolar disorder) or active substance abuse.
- Medical record documentation of a physical disorder with associated functional impairment (e.g., Parkinson's disease, stroke, congestive heart failure, etc.).
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01225328
Start Date
October 1 2010
End Date
April 1 2014
Last Update
December 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756